Early Resolution Of Bilateral Sudden Sensorineural Hearing Loss Due To Acute Carbon Monoxide Intoxication With Normobaric Oxygen, Systemic Steroid, Dextran And Piracetam Treatment

10.5580/17bb ◽  
2007 ◽  
Vol 6 (1) ◽  
2013 ◽  
Vol 24 (2) ◽  
pp. 432-434 ◽  
Author(s):  
Elif Baysal ◽  
Orhan Tunç ◽  
Tekin Baglam ◽  
Cengiz Durucu ◽  
Arzu Oz ◽  
...  

2021 ◽  
Vol 124 (1) ◽  
pp. 35-42
Author(s):  
Yoshihiko Hiraga ◽  
Koichiro Wasano ◽  
Taiji Kawasaki ◽  
Nobuyoshi Tsuzuki ◽  
Sosuke Sahara ◽  
...  

2012 ◽  
Vol 270 (4) ◽  
pp. 1255-1261 ◽  
Author(s):  
Christian Rohrmeier ◽  
Nikola Koemm ◽  
Philipp Babilas ◽  
Philipp Prahs ◽  
Juergen Strutz ◽  
...  

1993 ◽  
Vol 86 (10) ◽  
pp. 1397-1401
Author(s):  
Tsuyoshi Yoshihiro ◽  
Hidekazu Yamamoto ◽  
Takeshi Akisada ◽  
Junshi Yamakawa ◽  
Takumi Hayashi ◽  
...  

Author(s):  
Kyungil Jang ◽  
So Yun Lim ◽  
Eun-Ju Jeon ◽  
Hyun Jin Lee

Background and Objectives Steroid treatment is used as a main treatment modality for sudden sensorineural hearing loss (SSNHL). Intratympanic injection of steroid (ITS) has been used and its therapeutic efficacy reported as being comparable to the systemic steroid administration (SS). This study compares the hearing outcomes of using ITS and SS simultaneously and SS alone.Subjects and Method Retrospective chart review was performed for 146 patients with SSNHL. The patients were divided into 2 groups according to the method of treatment (SS and ITS simultaneously vs. SS alone). The inclusion criteria were starting treatment within 7 days after onset, and follow up pure tone audiometry at least 4 weeks after treatment. Hearing gain for pure tone threshold of each frequency and average of 4 frequencies (500 Hz, 1000 Hz, 2000 Hz, and 4000 Hz) were compared between both groups.Results The improvement in PTA at 1-month follow-up was 27.3±20.0 dB HL in the simultaneous group and 19.1±19.5 dB HL in the SS alone group; this was not statistically significant. Complete or partial recovery at 1-month follow-up was observed in 65.3% of the simultaneous group and 69.6% of the SS alone group; this was also not significant.Conclusion There was no significant difference in hearing outcomes between the simultaneous and SS alone group. The simultaneous therapy does not appear to be superior to the SS alone therapy. Further studies using more population and longer follow-up periods are necessary.


2013 ◽  
Vol 2013 ◽  
pp. 1-2 ◽  
Author(s):  
Eriko Ogino-Nishimura ◽  
Takayuki Nakagawa ◽  
Ichiro Tateya ◽  
Harukazu Hiraumi ◽  
Juichi Ito

A 63-year-old man, who was diagnosed with sudden sensorineural hearing loss (SSHL), showed severe hypertension 10 hours after prednisolone administration. Subsequently, the patient suddenly died due to pulmonary edema. The autopsy indicated a pheochromocytoma in the right adrenal gland, and the cause of death was determined to be a pheochromocytoma crisis induced by systemic administration of prednisolone. Pheochromocytoma crisis is a life-threatening condition and can result from the use of corticosteroids. Physicians should consider the risk of a pheochromocytoma crisis due to systemic corticosteroids in the treatment of patients with sudden sensorineural hearing loss.


Sign in / Sign up

Export Citation Format

Share Document